Alpro account plan
Plant-based food production
At a glance
Alpro is Danone's plant-based brand in Europe, described as a EUR1 billion platform growing at high single digits in H1 2026.
Alpro is a plant-based food and beverage brand (beverages, yogurts, barista and meal-replacement drinks) owned by Danone, which is no. 1 worldwide in plant-based foods and beverages. Danone calls it "the leading plant-based brand and EUR1 billion platform" in Europe, where it grew high single digits in H1 2026. Alpro belongs to Danone's Essential Dairy & Plant-Based category (€13,158m, 48% of Danone's 2025 sales of €27,283m), reported within the Europe zone in 2025 and EMEA from 2026. Danone is the listed parent; Alpro publishes no separate figures in these documents.
Business units
Alpro (within Essential Dairy & Plant-Based)
EUR1 billion platformPlant-based beverages and yogurts, barista products and the new Meal To Go drinks, sold mainly in Europe. Danone says the high-protein and Greek-style plant-based yogurt ranges perform very well and that Alpro keeps delivering competitive growth.
Essential Dairy & Plant-Based (Danone category)
48% of 2025 sales (€13,158m)Alpro's category at Danone: yogurts, coffee creations, desserts and plant-based beverages and alternatives, with brands including Activia, Oikos, Alpro and Silk. EDP grew +3.5% like-for-like in 2025 with a margin of 8.5%.
Silk (Danone's US plant-based brand)
Danone's US plant-based brand, repositioned on the Alpro model. In 2025 North America plant-based performance was called unsatisfactory, and Silk Protein yogurt and shakes have been launched in 2026.
Strategic priorities
- From plant-based to plant-powered
- The CEO describes Alpro's move "from being plant-based to being plant-powered", with a focus on the benefits it delivers rather than on ingredients or opposition to milk.
- Full range across beverages and yogurt
- Danone talks of "playing the full piano between beverages and yogurt", and is expanding the range, especially in yogurts, for flexitarian diets, with high-protein and Greek-style plant-based yogurts.
- Meal To Go and convenience
- The Meal To Go drinks offer 20 grams of protein and 26 essential vitamin and minerals, launched in Germany and being rolled out across Europe. Danone targets people working, at lunchtime, in proximity stores and out-of-home channels.
- Exporting the Alpro model to the US
- The team that turned Alpro around is deploying the approach for Silk in the US; the CEO expects "progress in the next 12 months".
- Group strategy: Renew Danone Chapter 2
- Danone pivots categories towards protein and gut health and broadens business models; mid-term guidance for 2025-2028 is 3-5% like-for-like sales growth.
Latest results
In H1 2026 Alpro delivered high single-digit growth in Europe, with innovation as a key growth driver. Danone's H1 2026 sales were €13,936m, +3.5% like-for-like, and its EDP category grew +3.6% with a recurring operating margin of 7.1% (-68 bps). Danone confirmed 2026 guidance of 3% to 5% like-for-like sales growth with recurring operating income growing faster than sales.
Investments and deals
- Huel acquisition
- Danone signed a definitive agreement on March 23, 2026 to acquire Huel, a complete nutrition brand with strong direct-to-consumer sales; closing is expected in H2 2026. The CEO says Alpro Meal To Go plays in the same space but with a different positioning and route to market.
- MADE Group acquisition
- Agreement signed June 22, 2026 for the Melbourne-based group with more than €300m of sales, including plant-based coconut products; closing expected in H2 2026.
- Group capex
- Danone capex was €1,055m in 2025, mostly capacity for high protein and medical nutrition, and €414m in H1 2026.
Challenges and risks
- Plant-based in North America
- The CEO called the performance of the US plant-based and Coffee Creamers business "unsatisfactory" and said "I'm not happy for a while now with Silk"; a New Jersey facility closure was mentioned in June 2026.
- EDP margin pressure
- The EDP recurring operating margin fell 68 bps to 7.1% in H1 2026, against a +12 bps group margin.
- Cost inflation and the Middle East
- Danone says the Middle East conflict that began in February 2026 inflates energy, transport, packaging and some agricultural costs.
- Changing consumer preferences
- Fast changes in consumer preferences are one of Danone's risks rated "strong".
What leadership says
“What we did very well in Europe is to pivot the brand from being ingredients-driven to being benefit-driven and from being built as in opposition to milk, to being built for itself because of the benefits it was bringing.”
“We have a model that is working extremely well in Europe.”
“We are making the healthy choice, the easy choice.”
Where a supplier can help
- Convenience channel launch support
- Meal To Go is being rolled out across Europe towards out-of-home and proximity stores: suppliers of out-of-home distribution, merchandising or retail data could help the rollout.
- Innovation and product claims
- Alpro's priority is benefit-led innovation in protein, Greek-style yogurt and meal replacement: suppliers of consumer insight, ingredient and nutrition science or claims substantiation fit this.
- Integration of Huel and MADE
- With Huel and MADE Group closing in H2 2026, partners in direct-to-consumer, community marketing and cross-border integration could be relevant.
- US turnaround playbook
- Danone is applying the Alpro playbook to Silk in the US after unsatisfactory plant-based results: suppliers in marketing effectiveness, supply chain or capacity planning could help.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Alpro?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Universal Registration Document 2025 (Annual Financial Report)
- Danone is a health-focused food group with three categories: Essential Dairy & Plant-Based (EDP, 48% of 2025 sales, €13,158m), Specialized Nutrition (infant formula and medical nutrition, 34%, €9,277m) and Waters (18%, €4,848m). It is no. 1 worldwide in fresh dairy and in plant-based foods and beverages, no. 2 in packaged waters and early life nutrition, no. 4 in adult medical nutrition. 88,670 employees and 151 production sites at end 2025.
- FY2025: sales €27,283m, +4.5% like-for-like (volume/mix +2.7%, price +1.8%) but -0.3% reported after a -5.0% currency effect; recurring operating income €3,665m, margin 13.4% (+44 bps); recurring EPS €3.80 (+4.6%); free cash flow €2,799m; ROIC 10.7% (+62 bps); dividend €2.25 (+4.7%). Reported net income fell 9.7% to €1,825m because of €725m of non-recurring costs (transformation projects in Europe and Indonesia, impairments).
- Growth by zone (LFL): Europe +2.3% (36% of sales), North America +2.0% (23%, "softer growth"), China, North Asia & Oceania +11.7% (14%, entirely volume/mix), Latin America +6.0%, Asia-Middle East-Africa +5.6%. By category: EDP +3.5% (margin 8.5%), Specialized Nutrition +7.4% (margin 21.7%, +112 bps), Waters +1.9% (margin 10.9%).
- The United States is the largest country (20% of sales), China second (12%, and the largest profit contributor); the top-5 markets are 51% of sales. The top ten customers are about 20% of sales, the top five about 14%. Channels outside mass retail (pharmacies, hospitals, homecare, away-from-home, e-commerce) are now over 50% of sales and grew 2-3x faster than mass retail in 2025.
- Strategy: "Renew Danone" Chapter 2 (since June 2024) pivots categories towards protein and gut health, broadens business models (away-from-home, medical nutrition, homecare), expands in the US, India and South-East Asia, and moves "to the front foot" on M&A. Mid-term guidance 2025-2028: 3-5% LFL sales growth, recurring operating income growing faster than sales, structurally double-digit ROIC, long-term ambition of €3bn free cash flow.
- 2025 M&A: 96% of Kate Farms (US plant-based medical nutrition, no. 1 doctor-recommended) for €839m ($983m) on July 1, 2025, creating a US medical nutrition platform; The Akkermansia Company (biotics, Belgium); disposal of the Iranian dairy business (€77m loss); sale of Proviva/Lunnarp (Sweden) signed. Capex rose to €1,055m, mostly capacity for high protein and medical nutrition.
- Organisation: from January 1, 2026 Danone runs three zones (EMEA, Americas, APAC) instead of five; Shane Grant (Deputy CEO, CEO Americas) left in June 2025. Early 2026 events: targeted recall of infant formula batches (January 23, 2026) and consolidation of the Australian dairy JV with Saputo at 51% (February 12, 2026).
- Main risks rated "strong": over-reliance on principal markets (notably China, where infant formula sold is mostly made abroad), packaging/plastics regulation, fast changes in consumer preferences, raw material and energy price volatility (materials are ~75% of COGS, about €10bn a year), climate change. Medium: retail shift (discounters, private label), currency, legal/regulatory, cybersecurity, food safety, talent, business transformation.
- 2026 guidance: like-for-like sales growth of 3% to 5% with recurring operating income growing faster than sales. CEO Antoine de Saint-Affrique: "there is more to do and some areas still require further progress."
- 2026 Interim Financial Report (six months ended June 30, 2026)
- H1 2026 sales €13,936m, +3.5% like-for-like (volume/mix +1.7%, price +1.8%), +1.4% reported with a +0.7% scope effect (Kate Farms, Australian dairy JV) and -3.3% from currencies.
- Recurring operating income €1,854m, margin 13.3% (+12 bps): strong productivity gains including +84 bps in overheads offset a -54 bps fall in margin from operations (infant formula recall in EMEA, first effects of inflation) and -25 bps of reinvestment in A&P, product superiority and capabilities.
- New three-zone reporting: EMEA €6,133m (+2.1% LFL, margin 10.4% flat), Americas €4,688m (+3.9%, margin 9.6%, +31 bps), APAC €3,116m (+5.6%, margin 24.7%). By category: EDP €6,681m (+3.6%, margin 7.1%, -68 bps), Specialized Nutrition €4,730m (+3.2%, margin 22.1%), Waters €2,525m (+3.6%, margin 13.3%, +196 bps).
- Recurring EPS €1.92 (+0.9%); reported net income group share €1,175m (+13.0%), helped by a €122m remeasurement gain on the Australian JV; non-recurring operating expense -€161m (transformation projects €82m, recall costs €42m).
- Free cash flow €852m (vs €1,172m): capex up to €414m and a -€567m working capital outflow from security stocks built up because of the Middle East situation. Net debt €8,975m (+€544m since December); €1.6bn triple-tranche bond issued in March; dividend of €2.25 paid in May (€1,440m).
- Deals signed and pending close in H2 2026: acquisition of Huel (complete nutrition, UK/Europe/US, direct-to-consumer), acquisition of MADE Group (Australia, >€300m sales, high-protein RTD, gut-health yogurts, coconut products) and of the remaining 49% of the Saputo dairy JV, and a dairy joint venture with Arcor in Argentina that deconsolidates Danone Argentina (assets held for sale €240m).
- Risks: no new risk factors, but the Middle East conflict that began in February 2026 is disrupting logistics and inflating energy, transport, packaging and some agricultural costs; the January 2026 infant formula recall has triggered claims in several jurisdictions, with no provision booked.
- 2026 guidance confirmed: like-for-like sales growth of 3% to 5% with recurring operating income growing faster than sales.
- Danone FY 2025 results conference call transcript: Alpro passages (CEO Antoine de Saint-Affrique, CFO Juergen Esser)
- Alpro is described as "another key growth engine" in Europe, "the leading plant-based brand and EUR1 billion platform".
- Strategy: evolve Alpro "beyond an ingredient-led dairy alternative into a benefit-led plant-powered" nutritional complement to dairy, with a wider yogurt range for flexitarian diets.
- Alpro launched "Meal To Go" drinks, a plant-based meal replacement with 20 grams of protein and 26 essential vitamin and minerals, first in Germany; out-of-home channels are said to grow much faster than mass retail.
- In Q4 2025 Alpro again posted "very solid competitive growth"; Europe grew +2.3% like-for-like for the full year with recurring operating margin at 12.0%.
- The Alpro turnaround leader now runs the category and creamers in the US, where Silk and plant-based were unsatisfactory.
- Danone H1 2026 results conference call transcript: Alpro passages (CEO Antoine de Saint-Affrique)
- "Alpro continues to deliver high single-digit growth in Europe in H1", with innovation as a key growth driver.
- The high-protein and Greek-style plant-based yogurt ranges "continue to perform very well"; Meal To Go is being rolled out across Europe after its launch in Germany; a matcha coconut ready-to-drink was launched.
- The CEO calls Alpro's move "from being plant-based to being plant-powered", "playing the full piano between beverages and yogurt", a "very, very efficient model" that he wants to replicate for Silk in the US.
- On Huel, he says Alpro Meal To Go plays in the same space but with "a positioning that is very different and with a route to market that is very different"; he sees the brands as complementary.
- dbAccess Global Consumer Conference 2026 fireside chat with Danone: Alpro passages (CEO Antoine de Saint-Affrique)
- The CEO explains the Alpro turnaround: five years ago Alpro and Silk "were more or less in the same state", built on ingredients (almond, soy) and positioned against milk.
- In Europe the brand pivoted "from being ingredients-driven to being benefit-driven" and from opposition to milk to being "built for itself".
- Product proof points he cites: an Alpro yogurt is "a great yogurt experience", the barista gives a foam "that is amazing in a cappuccino", the beverage has "fibers, calcium minerals you don't find in other products".
- The same team that turned Alpro around has been put in charge in the US since January; he expects "progress in the next 12 months".
Questions about Alpro
Who owns Alpro?
Alpro is part of Danone, the listed group, within its Essential Dairy & Plant-Based category. Danone is no. 1 worldwide in plant-based foods and beverages.
How big is Alpro?
Danone describes Alpro as a EUR1 billion platform in Europe. It grew high single digits in H1 2026.
What is Alpro's strategy?
Danone says it moved Alpro from plant-based to plant-powered, focusing on benefits, a full range across beverages and yogurt, protein, and meal replacement such as Meal To Go.
Who leads Danone, Alpro's parent?
Antoine de Saint-Affrique is Chief Executive Officer of Danone and Juergen Esser is the Chief Financial Officer.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)